AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Syra Health Corp. Class A Common Stock

$0.94 +$0.85 (+980.46%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0.9
Day Range
$0.9$0.94
Year Range
$0.05$1.15
Market Cap
11.22M
AVG Volume
38.25K
Trailing/Forward PE
104.44/-
PEG ratio
0.15
Dividend Yield
-
Next Earnings Date
2026-11-18
Primary Exchange
Other OTCUS
Revenue (USD)
01M2M3M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Revenue (USD) by quarter
PeriodRevenue (USD)
26 Q22.39M
26 Q12.27M
25 Q41.73M
25 Q31.69M
25 Q21.95M
25 Q11.86M
24 Q42.01M
24 Q32.25M
24 Q21.97M
24 Q11.75M
Net Income (USD)
-1.5M-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2250.24K
26 Q1240.98K
25 Q4-134.57K
25 Q3-225.9K
25 Q2-63.6K
25 Q1-472.26K
24 Q4-504.4K
24 Q3-417.54K
24 Q2-1.39M
24 Q1-1.45M
Operating Income (USD)
-1.5M-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2251.57K
26 Q1190.98K
25 Q4-135.66K
25 Q3-232.17K
25 Q2-63.16K
25 Q1-473.33K
24 Q4-501.67K
24 Q3-428.91K
24 Q2-1.39M
24 Q1-1.44M
EBITDA (USD)
-1.5M-1M-500K0500K24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA EBITDA (USD) by quarter
PeriodEBITDA (USD)
26 Q2251.57K
26 Q1244.5K
25 Q4-128K
25 Q3-221.81K
25 Q2-53.76K
25 Q1-462.24K
24 Q4-491.59K
24 Q3-389.73K
24 Q2-1.37M
24 Q1-1.43M
Cash Flows (USD)
-2M-1M01M2M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Cash Flows (USD) by quarter
PeriodCash Flows (USD)
26 Q2-718.76K
26 Q11.36M
25 Q4-289.3K
25 Q3-244.31K
25 Q2-72.48K
25 Q1158.23K
24 Q4-214.72K
24 Q3-413.3K
24 Q2-1.51M
24 Q1-806.36K
EPS (USD)
-0.3-0.2-0.1-00.124 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA EPS (USD) by quarter
PeriodEPS (USD)
26 Q20.02
26 Q10.02
25 Q4-0.01
25 Q3-0.02
25 Q2-0.01
25 Q1-0.07
24 Q4-0.07
24 Q3-0.06
24 Q2-0.21
24 Q1-0.22
Expenses (USD)
-500K0500K1M1.5M2MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Expenses (USD) by quarter
PeriodExpenses (USD)
26 Q2283.83K
26 Q1779.22K
25 Q4724.64K
25 Q3781.32K
25 Q2810.08K
25 Q11.06M
24 Q4949.76K
24 Q3323.13K
24 Q21.73M
24 Q11.74M
Cash & Debt (USD)
01M2M3M4MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Cash & Debt (USD) by quarter
PeriodCash & Debt (USD)
26 Q22.12M
26 Q12.92M
25 Q41.61M
25 Q31.98M
25 Q22.31M
25 Q12.49M
24 Q42.4M
24 Q32.7M
24 Q21.59M
24 Q13.24M
Debt ratios
-20-100102024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Debt ratios by quarter
PeriodDebt ratios
26 Q2-13.5
26 Q117.91
25 Q41.7
25 Q31.42
25 Q21.57
25 Q10.87
24 Q40.53
24 Q30.51
24 Q20.28
24 Q10.89
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Margins by quarter
PeriodMargins
26 Q244.53%
26 Q142.72%
25 Q434.09%
25 Q332.85%
25 Q238.69%
25 Q131.71%
24 Q422.69%
24 Q329.66%
24 Q217.77%
24 Q117.11%
Return on Capital
-80%-60%-40%-20%0%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Return on Capital by quarter
PeriodReturn on Capital
26 Q29.5%
26 Q110.2%
25 Q4-6.41%
25 Q3-10.22%
25 Q2-2.63%
25 Q1-19.22%
24 Q4-17.52%
24 Q3-12.54%
24 Q2-66.45%
24 Q1-41.95%
Shares Outstanding
05M10M15M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Shares Outstanding by quarter
PeriodShares Outstanding
26 Q213.18M
26 Q111.94M
25 Q411.94M
25 Q311.94M
25 Q211.94M
25 Q17.26M
24 Q47.26M
24 Q37.26M
24 Q26.6M
24 Q16.5M
Book Value Per Share (USD)
00.20.40.624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Book Value Per Share (USD) by quarter
PeriodBook Value Per Share (USD)
26 Q20.2
26 Q10.2
25 Q40.18
25 Q30.19
25 Q20.2
25 Q10.34
24 Q40.4
24 Q30.46
24 Q20.32
24 Q10.53
Total Assets (USD)
02M4M6M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
SYRA Total Assets (USD) by quarter
PeriodTotal Assets (USD)
26 Q23.83M
26 Q13.94M
25 Q42.77M
25 Q33.26M
25 Q23.47M
25 Q13.72M
24 Q43.68M
24 Q34.43M
24 Q23.24M
24 Q14.55M
Employee Count
020406080202320242025
SYRA Employee Count by quarter
PeriodEmployee Count
202538
202457
202378
PE Ratio
7580859095med 90.69Aug 26Aug 26Aug 26Sep 26Sep 26
SYRA PE Ratio by quarter
PeriodPE Ratio
Sep 2694.72
Sep 2693.72
Aug 2680.62
Aug 2678.6
Aug 2690.69
Free Cash Flow Yield
-800%-600%-400%-200%0%200%med -57.13%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SYRA Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 260.88%
Sep 260.89%
Aug 261.04%
Aug 261.07%
Aug 260.92%
Aug 269.89%
Jul 268.67%
Jul 269.45%
Jul 267.83%
Jul 2612.06%
Jul 269.29%
Jun 2611.72%
Jun 2614.07%
Jun 2612.29%
Jun 2612.45%
May 2611.51%
May 2612.85%
May 2611.73%
May 2611.51%
May 26-7.81%
Apr 26-7.98%
Apr 26-9.38%
Apr 26-11.31%
Apr 26-15.68%
Mar 26-22.87%
Mar 26-21.15%
Mar 26-35.73%
Mar 26-34.74%
Feb 26-31.26%
Feb 26-34.66%
Feb 26-33.26%
Feb 26-39.08%
Jan 26-39.08%
Jan 26-39.08%
Jan 26-39.08%
Jan 26-36.78%
Jan 26-35.94%
Dec 25-31.26%
Dec 25-28.95%
Dec 25-52.11%
Dec 25-45.31%
Nov 25-41.69%
Nov 25-44.66%
Nov 25-44.66%
Nov 25-67.79%
Oct 25-59.76%
Oct 25-56.77%
Oct 25-47.81%
Oct 25-53.43%
Oct 25-54.07%
Sep 25-64.88%
Sep 25-69.88%
Sep 25-46.82%
Sep 25-50.47%
Aug 25-72.09%
Aug 25-67.79%
Aug 25-57.49%
Aug 25-320.41%
Aug 25-306.01%
Jul 25-272.35%
Jul 25-228.86%
Jul 25-358.35%
Jul 25-283.7%
Jun 25-272.35%
Jun 25-247.59%
Jun 25-336.23%
Jun 25-336.23%
May 25-320.41%
May 25-283.7%
May 25-292.85%
May 25-328.13%
May 25-385.83%
Apr 25-698.49%
Apr 25-389.54%
Apr 25-201.96%
Apr 25-215.38%
Mar 25-142.85%
Mar 25-124.65%
Mar 25-119.12%
Mar 25-157.11%
Feb 25-152.45%
Feb 25-152.45%
Feb 25-150.59%
Feb 25-149.86%
Jan 25-127.57%
Jan 25-122.26%
Jan 25-125.95%
Jan 25-102.92%
Jan 25-137.27%
Dec 24-138.03%
Dec 24-162.48%
Dec 24-148.24%
Dec 24-152.53%
Nov 24-140.32%
Nov 24-168.74%
Nov 24-173.87%
Nov 24-150.23%
Nov 24-143.55%
Oct 24-166.51%
Oct 24-168.26%
Price to Sales
00.511.52med 0.22Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SYRA Price to Sales by quarter
PeriodPrice to Sales
Sep 261.53
Sep 261.51
Aug 261.3
Aug 261.27
Aug 261.47
Aug 261
Jul 261.14
Jul 261.05
Jul 261.26
Jul 260.82
Jul 261.06
Jun 260.84
Jun 260.7
Jun 260.8
Jun 260.79
May 260.86
May 260.77
May 260.84
May 260.86
May 260.79
Apr 260.78
Apr 260.66
Apr 260.55
Apr 260.4
Mar 260.27
Mar 260.29
Mar 260.17
Mar 260.14
Feb 260.16
Feb 260.14
Feb 260.15
Feb 260.13
Jan 260.13
Jan 260.13
Jan 260.13
Jan 260.14
Jan 260.14
Dec 250.16
Dec 250.17
Dec 250.1
Dec 250.11
Nov 250.12
Nov 250.11
Nov 250.11
Nov 250.1
Oct 250.11
Oct 250.12
Oct 250.14
Oct 250.13
Oct 250.12
Sep 250.1
Sep 250.1
Sep 250.14
Sep 250.13
Aug 250.09
Aug 250.1
Aug 250.12
Aug 250.08
Aug 250.08
Jul 250.09
Jul 250.11
Jul 250.07
Jul 250.09
Jun 250.09
Jun 250.1
Jun 250.07
Jun 250.07
May 250.08
May 250.09
May 250.08
May 250.07
May 250.1
Apr 250.05
Apr 250.09
Apr 250.18
Apr 250.17
Mar 250.26
Mar 250.3
Mar 250.31
Mar 250.37
Feb 250.38
Feb 250.38
Feb 250.38
Feb 250.39
Jan 250.45
Jan 250.47
Jan 250.46
Jan 250.56
Jan 250.42
Dec 240.42
Dec 240.36
Dec 240.39
Dec 240.38
Nov 240.41
Nov 240.34
Nov 240.33
Nov 240.39
Nov 240.4
Oct 240.38
Oct 240.37
EV/EBITDA
5560657075med 67.57Aug 26Aug 26Aug 26Sep 26Sep 26
SYRA EV/EBITDA by quarter
PeriodEV/EBITDA
Sep 2671.18
Sep 2670.27
Aug 2658.56
Aug 2656.76
Aug 2667.57
Price/Operating Cashflow
050100150med 10.11May 26May 26Jun 26Jul 26Jul 26Aug 26Sep 26
SYRA Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 26112.92
Sep 26111.71
Aug 2696.1
Aug 2693.7
Aug 26108.11
Aug 2610.11
Jul 2611.53
Jul 2610.58
Jul 2612.76
Jul 268.29
Jul 2610.76
Jun 268.53
Jun 267.11
Jun 268.13
Jun 268.03
May 268.69
May 267.78
May 268.53
May 268.69
Price to Book
0246med 0.66Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SYRA Price to Book by quarter
PeriodPrice to Book
Sep 264.7
Sep 264.65
Aug 264
Aug 263.9
Aug 264.5
Aug 263.23
Jul 263.69
Jul 263.39
Jul 264.08
Jul 262.65
Jul 263.44
Jun 262.73
Jun 262.27
Jun 262.6
Jun 262.57
May 262.78
May 262.49
May 262.73
May 262.78
May 262.73
Apr 262.67
Apr 262.28
Apr 261.89
Apr 261.36
Mar 260.93
Mar 261.01
Mar 260.6
Mar 260.49
Feb 260.54
Feb 260.49
Feb 260.51
Feb 260.43
Jan 260.43
Jan 260.43
Jan 260.43
Jan 260.46
Jan 260.47
Dec 250.54
Dec 250.58
Dec 250.32
Dec 250.37
Nov 250.41
Nov 250.38
Nov 250.38
Nov 250.33
Oct 250.38
Oct 250.4
Oct 250.47
Oct 250.42
Oct 250.42
Sep 250.35
Sep 250.32
Sep 250.48
Sep 250.45
Aug 250.31
Aug 250.33
Aug 250.39
Aug 250.25
Aug 250.26
Jul 250.3
Jul 250.35
Jul 250.22
Jul 250.28
Jun 250.3
Jun 250.33
Jun 250.24
Jun 250.24
May 250.25
May 250.28
May 250.28
May 250.25
May 250.26
Apr 250.15
Apr 250.26
Apr 250.51
Apr 250.47
Mar 250.72
Mar 250.82
Mar 250.86
Mar 250.86
Feb 250.88
Feb 250.88
Feb 250.89
Feb 250.9
Jan 251.06
Jan 251.1
Jan 251.07
Jan 251.31
Jan 250.98
Dec 240.98
Dec 240.83
Dec 240.91
Dec 240.88
Nov 240.96
Nov 240.8
Nov 240.77
Nov 240.9
Nov 240.94
Oct 241.27
Oct 241.26
Syra Health Corp. Class A Common Stock
SYRA
Stockpicker

Video analysis: SYRA

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SYRA

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

prnewswire.com · 3 Sep 2026

Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy

CARMEL, Ind., Sept. 3, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that, in partnership with HealthSync, it has been accepted into the CMS (Centers for Medicare & Medicaid) ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) model.

Syra Health, Wake County Public Health Expand Wellness Partnership

prnewswire.com · 1 Sep 2026

Syra Health, Wake County Public Health Expand Wellness Partnership

CARMEL, Ind., Sept. 1, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the expansion of its partnership with Wake County Public Health, located in North Carolina.

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

prnewswire.com · 11 Aug 2026

Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter

Syra Health sustained profitability in Q2 2026, following the Company's first profitable quarter in Q1 2026, delivering net income of $250,242 compared with a net loss of $(63,596) in the prior-year period. Q2 2026 revenue grew 23% year-over-year to $2.4 million.

Syra Health To Announce Second Quarter 2026 Financial Results

prnewswire.com · 4 Aug 2026

Syra Health To Announce Second Quarter 2026 Financial Results

CARMEL, Ind., Aug. 4, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today that it will report financial results for the three months ended June 30, 2026, on Tuesday, August 11, 2026.

Syra Health (NASDAQ:SYRA) Trading Down 4.3%  – What’s Next?

defenseworld.net · 23 Jul 2026

Syra Health (NASDAQ:SYRA) Trading Down 4.3% – What’s Next?

Syra Health Corp. (NASDAQ: SYRA - Get Free Report) dropped 4.3% during mid-day trading on Wednesday. The company traded as low as $0.7610 and last traded at $0.7610. Approximately 5,296 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 50,661 shares. The stock had previously closed at $0.7952.

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

prnewswire.com · 7 Jul 2026

Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy

CARMEL, Ind., July 7, 2026 /PRNewswire/ -- Syra Health Corp. (OTCQB: SYRA) ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Dr. Cori McMahon, PsyD, NCCE, as Chief Medical Officer.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.